利喷西平
促销价¥{{model.attbuying.price}}
市场价¥0.00
累计销量0 累计评价0 人评论
-
{{item.title}}
| 包装规格: | 25mg 50mg 100mg in glass bottle |
| 产品描述: | 基本信息 产品编号: R10497 产品名称: Rispenzepine CAS: 96449-05-7 储存条件 粉末 -20℃ 四年 分子式: C19H20N4O2 溶于液体 -80℃ 二年 分子量: 336.39 化学名: 11-(1-methylpiperidine-3-carbonyl)-6,11-dihydro-5H-benzo[b]pyrido[2,3-e][1,4]diazepin-5-one Solubility (25°C): 体外: DMSO Ethanol Water 体内(现配现用): <1mg/ml表示微溶或不溶。 普西唐提供的所有化合物浓度为内部测试所得,实际溶液度可能与公布值有所偏差,属于正常的批间细微差异现象。 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;⼀旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 生物活性 产品描述 一种选择性毒蕈碱受体 (M1 和 M3 受体亚型) 拮抗剂。 靶点 M1,and M3 receptor 体外研究 The presence of muscarinic autoreceptors in human and guinea pig trachea is investigated by comparing the effects of the muscarinic receptor antagonists Pirenzepine (M1),Methoctramine (M2),4-DAMP (M3),and Rispenzepine (M1/M3) on cholinergic neural contractile responses evoked by electrical field stimulation (EFS) and [3H]ACh release.The M1,M1/M3,or M3 antagonists inhibit the EFS-evoked cholinergic contractile response in a concentration-dependent manner (4-DAMP>Rispenzepine>Pirenzepine), whereas Methoctramine facilitates this response at low concentrations (<3μM).In ACh release studies,the M3 antagonist has no significant effect,whereas Pirenzepine,Methoctramine,and Rispenzepine significantly increase ACh release in guinea pig trachea.Rispenzepine almost completely inhibits cholinergic,contractile responses at 0.3μM (92.7±6.2% inhibition,n=6,p<0.05;pD2 value of 7.31±0.15) . |
| 保存条件: | -20℃ |
-
蜀牛玻璃三角瓶
¥85.00 销量:16
-
15mL锥底离心管,袋装灭菌,橙色盖
¥636.00 销量:12
-
UFC5030BK 超滤管[0.5ml 30KD]
¥52.00 销量:10
-
UFC5010BK 超滤管[0.5ml 10KD]
¥52.00 销量:10
-
20×TBST缓冲液
¥130.00 销量:10
-
10mL移液管,易撕型全塑包装
¥456.00 销量:10
-
¥158.00
通用型 DNA 纯化回收试剂盒 -
¥158.00
质粒快速小提试剂盒 -
¥828.00
100mm TC细胞培养皿,袋装灭菌

